WARSAW, Ind., Aug. 21, 2024 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will present at two upcoming healthcare conferences in September. The team will be presenting at the Wells Fargo 2024 Healthcare Conference on Thursday, September 5, 2024, at 8:00 a.m. ET.
Subsequently, the team will present at the Morgan Stanley Annual Global Healthcare Conference on Friday, September 6, 2024, at 9:15 a.m. ET.
A live webcast of the presentations can be accessed via Zimmer Biomet’s Investor Relations website at https://investor.zimmerbiomet.com. The webcasts will be archived for replay following the conferences.
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet.
Media |
Investors |
Heather Zoumas-Lubeski |
Zach Weiner |
(445) 248-0577 |
(908) 591-6955 |
SOURCE Zimmer Biomet Holdings, Inc.
Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB:…
Philadelphia, Pennsylvania--(Newsfile Corp. - June 2, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company")…
ARLINGTON, Va.--(BUSINESS WIRE)--The National Evaluation System for health Technology (NEST), an initiative of the Medical…
ARLINGTON, Va., June 2, 2025 /PRNewswire/ -- BioInformatics, a Science and Medicine Group company, has released…
New Collaboration Integrates Low-Cost Cash Pay Options into Scripta's Rx Navigation™ Platform, Supporting Fiduciary Responsibility…
Organization's 6,000-genome effort will power global ALS research through detailed long-read sequencing data made freely…